Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial

CONCLUSION: The study results showed that short-term curcumin-piperine supplementation significantly decreased CRP, AST, and increased hemoglobin in COVID-19 patients admitted to the ICU. Based on these promising findings, curcumin appears to be a complementary treatment option for COVID-19 patients, although some parameters were not affected by the intervention.PMID:37378780 | DOI:10.1007/978-3-031-28012-2_22

Source: Advances in Experimental Medicine and Biology - June 28, 2023 Category: Research Authors: Gholamreza Askari Mohammad Bagherniya Zahra Kiani Babak Alikiaii Mahdiye Mirjalili Mehrnaz Shojaei Shirin Hassanizadeh Mahdi Vajdi Awat Feizi Muhammed Majeed Amirhossein Sahebkar Source Type: research